Pyrazolo-pyrimidines as casein kinase II (CK2) modulators

Details for Australian Patent Application No. 2006304875 (hide)

Owner Exelixis, Inc.

Inventors Bussenius, Joerg; Peto, Csaba J.; Kim, Angie Inyoung; Manalo, Jean-Claire Limun; Kennedy, Abigail R.; Costanzo, Simona; Rice, Kenneth D.

Agent Davies Collison Cave

Pub. Number AU-A-2006304875

PCT Pub. Number WO2007/048066

Priority 60/729,348 21.10.05 US

Filing date 23 October 2006

Wipo publication date 26 April 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/048066 Priority application(s): WO2007/048066

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304876-c-KIT oncogene mutations in melanoma

2006304874-Pyrimidinones as casein kinase II (CK2) modulators